Skip to content
healthcare.dev

Rasagiline mesylate

NDC 71921-408, Rasagiline mesylate, tablet, from Florida Pharmaceutical Products, LLC.

Product NDC
71921-408
Status
Listed
Labeler
Florida Pharmaceutical Products, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206153
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71921-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE1 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
71921-408-337192104083330 TABLET in 1 BOTTLE (71921-408-33)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3b57a1c9-0ad9-40cf-a972-29851a658489
  • NADAC price for package 71921040833

    GET /v1/drugs/nadac/71921040833

Use it

Look up 71921-408 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71921-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71921-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.